Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Digit. Health

Sec. Health Technology Implementation

Feasibility and Reliability of a Smartwatch to Detect Atrial Fibrillation after Cardiac Surgery: a prospective study

Provisionally accepted
Konrad  SchreierKonrad Schreier1,2*Michael  BorgerMichael Borger2Alireza  Sepehri ShamlooAlireza Sepehri Shamloo2Lukas  HofmannLukas Hofmann1,2Thomas  SchröterThomas Schröter2Sandra  EifertSandra Eifert2Angeliki  DarmaAngeliki Darma2Christian  EtzChristian Etz3Sergey  LeontyevSergey Leontyev2Martin  MisfeldMartin Misfeld2ANDREAS  BOLLMANNANDREAS BOLLMANN2Arash  AryaArash Arya4,5
  • 1Leipzig University, Leipzig, Germany
  • 2Herzzentrum Leipzig Universitatsklinik, Leipzig, Germany
  • 3Universitatsmedizin Rostock, Rostock, Germany
  • 4Universitatsklinikum Halle Saale, Halle (Saale), Germany
  • 5Martin-Luther-Universitat Halle-Wittenberg, Halle (Saale), Germany

The final, formatted version of the article will be published soon.

Background: Atrial fibrillation, the world's predominant cardiac arrhythmia, frequently emerges as a complication post-cardiac surgery, leading to serious outcomes like strokes, heart failures, and even death. Due to its often-silent nature, detecting it can be challenging. Smartwatches present a potential solution, offering screening that is more rigorous. Objective: This prospective observational study sought to assess the Withings Scanwatch's efficacy in identifying postoperative atrial fibrillation. Methods: After cardiac surgery, patients received a Withings Scanwatch. Over a span of 24 hours, both the smartwatch's photoplethysmography sensor and standard telemetry kept track of any atrial fibrillation incidents. Results: At the end of the study, data from 260 patients was available for assessment. Atrial fibrillation was identified in 32 of these patients, either via telemetry or the smartwatch. Our data revealed a sensitivity of 69.0%, specificity of 98.7%, a positive predictive value of 87.0%, and a negative predictive value of 96.2%. Conclusions: This clinical study is the first to evaluate the photoplethysmography sensor of the Withings Scanwatch, and it shows that the Scanwatch has high a specificity and moderate sensitivity in detecting postoperative atrial fibrillation. Thus, Scanwatch may support the conventional screening for atrial fibrillation, and potentially reducing complications and costs of atrial fibrillation. Because of lower than expected sensitivity this technology cannot replace conventional monitoring in postoperative patients.

Keywords: Atrial Fibrillation, cardiac surgery, Monitoring, screening, SmartWatch

Received: 03 Oct 2025; Accepted: 11 Dec 2025.

Copyright: © 2025 Schreier, Borger, Sepehri Shamloo, Hofmann, Schröter, Eifert, Darma, Etz, Leontyev, Misfeld, BOLLMANN and Arya. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Konrad Schreier

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.